XERS
XERS
NASDAQ · Pharmaceuticals

Xeris Biopharma Holdings Inc

$8.20
+0.04 (+0.49%)
As of Sep 20, 10:12 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 11 85%
Hold 2 15%
Sell 0 0%
Price Target
Analyst Price Target +468.9% upside
Low Target $35.62
Average Target $46.65
High Target $60.75
Current Price $8.20
Current
$8.20
Target
$46.65
$35.62 $46.65 avg $60.75
Scenario Analysis
Bear Case
$35.62
334.4%
Low target
Base Case
$46.65
+468.9%
Avg target
Bull Case
$60.75
+640.9%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$10.08
-18.7% from high
52-Week Low
$5.25
+56.2% from low
Target vs 52W High
$46.65
+362.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +13.7%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +5.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.4%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +188.0%